Rivaroxaban for system suitability CRS (Y0002193)
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

Rivaroxaban for system suitability CRS (Y0002193)

● Auf Lager

Katalog-Nr.::PVE00473
CAS-Nr.::N/A
Summenformel::-
Molare Masse::-

Zusätzliche Informationen zu Rivaroxaban for system suitability CRS (Y0002193)

Parent drug

Rivaroxaban

Pharmakopöe-Synonyme

N/A

Other Synonyms

N/A

Beschreibung

The compound Rivaroxaban for system suitability CRS (Y0002193) is a highly characterized reference material that meets stringent regulatory standards | including those set by USP | EMA | JP | and BP. This product is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC) | particularly in the context of Rivaroxaban production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). Additionally | the product comes with a detailed Structure Elucidation Report (SER) | ensuring its precision and reliability for comprehensive analytical use.

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url